Apogee Therapeutics, Inc.
APGE
$75.88
$1.331.78%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -2.07% | 4.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.58% | 15.96% | |||
| Operating Income | 2.58% | -15.96% | |||
| Income Before Tax | 1.61% | -19.49% | |||
| Income Tax Expenses | -15.28% | -13.25% | |||
| Earnings from Continuing Operations | 1.63% | -19.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.63% | -19.44% | |||
| EBIT | 2.58% | -15.96% | |||
| EBITDA | 2.60% | -15.71% | |||
| EPS Basic | 2.20% | -18.96% | |||
| Normalized Basic EPS | 2.18% | -19.01% | |||
| EPS Diluted | 2.20% | -18.96% | |||
| Normalized Diluted EPS | 2.18% | -19.01% | |||
| Average Basic Shares Outstanding | 0.59% | 0.40% | |||
| Average Diluted Shares Outstanding | 0.59% | 0.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||